source
- Novo Nordisk's Q1 in four words: Pills, pricing, payments and pressureA million patients with obesity are already taking Novo Nordisk’s Wegovy pill, CEO Mike Doustdar said Wednesday, despite the market entry of Lilly’s Foundayo. Novo's pill had sales of 2.3 billion D…Endpoints · 2mo ago↗ source
- Opinion: STAT+: Ambiguous loss: a peculiar kind of grief in dementia careAmbiguous loss is at the heart of the dementia illness experience.STAT · 2mo ago↗ source
- Opinion: Dr. Glaucomflecken wants to make a stink“They don’t want this kind of scrutiny”: Why Dr. Glaucomflecken is getting involved in protests over an Oregon hospital system’s emergency department.STAT · 2mo ago↗ source